España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Artelo Biosciences
ARTL
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.04
-0.04
-3.70%
At close: -
$1.05
0.01
0.96%
After Hours: Nov 15, 6:58 PM EDT
Get Report
Comment
Q3 2024 Earnings were released on Tue Nov 12th, before the market open
Artelo Biosciences (ARTL) Forecast
News
Earnings
Artelo Biosciences (ARTL) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Artelo Biosciences (NASDAQ:ARTL) Stock
Artelo Biosciences Stock (NASDAQ: ARTL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 13, 2024
Artelo Biosciences Reports Data On Novel Non-...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Artelo ...
Benzinga Newsdesk
Tuesday, November 12, 2024
Artelo Biosciences Q3 2024 GAAP EPS $(0.35) B...
Benzinga Newsdesk
Tuesday, November 05, 2024
Artelo Biosciences Announces Acceptance Of AR...
Benzinga Newsdesk
Tuesday, October 01, 2024
EF Hutton Initiates Coverage On Artelo Biosci...
Benzinga Newsdesk
Wednesday, August 14, 2024
HC Wainwright & Co. Reiterates Buy on Artelo ...
Benzinga Newsdesk
Tuesday, August 13, 2024
Artelo Biosciences Q2 EPS $(0.75) Beats $(0.8...
Benzinga Newsdesk
Monday, July 15, 2024
Market-Moving News for July 15th
Benzinga Newsdesk
Artelo Biosciences shares are trading higher ...
Benzinga Newsdesk
Artelo Biosciences Receives FDA Clearance Of ...
Benzinga Newsdesk
Wednesday, July 03, 2024
Artelo Biosciences Presents Data From Preclin...
Benzinga Newsdesk
Monday, July 01, 2024
Artelo Biosciences Presents Preclinical Data ...
Benzinga Newsdesk
Wednesday, June 05, 2024
HC Wainwright & Co. Reiterates Buy on Artelo ...
Benzinga Newsdesk
Tuesday, June 04, 2024
Artelo Biosciences Announces Presentation Of ...
Benzinga Newsdesk
Wednesday, May 29, 2024
Artelo Biosciences Reports Data For Developin...
Benzinga Newsdesk
Wednesday, May 15, 2024
HC Wainwright & Co. Reiterates Buy on Artelo ...
Benzinga Newsdesk
Monday, May 13, 2024
Artelo Biosciences Q1 EPS $(0.78) Beats $(1.0...
Benzinga Newsdesk
Tuesday, April 23, 2024
Artelo Biosciences Reports Publication Peer-R...
Benzinga Newsdesk
Tuesday, April 02, 2024
HC Wainwright & Co. Maintains Buy on Artelo B...
Benzinga Newsdesk
Monday, March 25, 2024
Artelo Biosciences Earlier Reported Q4 EPS $(0.99) Misses $(0.56) Estimate
Happy Mohamed
Recap: Artelo Biosciences Q4 Earnings
Benzinga Insights
Artelo Biosciences FY23 EPS $(3.14) Vs $(3.56...
Benzinga Newsdesk
Wednesday, March 20, 2024
Artelo Biosciences Has Been Granted European ...
Benzinga Newsdesk
Wednesday, March 06, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tuesday, January 23, 2024
Artelo Biosciences Announces Publication Of N...
Benzinga Newsdesk
Monday, January 08, 2024
Artelo Biosciences Announces Selection Of Wor...
Benzinga Newsdesk
Thursday, December 21, 2023
Artelo Biosciences Filed U.S. Patent Application #20230404939: Solid Forms Of Cannabidiol And Uses Thereof
Charles Gross
Tuesday, December 05, 2023
Artelo Biosciences Presents New Preclinical D...
Benzinga Newsdesk
Thursday, November 30, 2023
Artelo Biosciences To Present Important New P...
Benzinga Newsdesk
Tuesday, November 14, 2023
HC Wainwright & Co. Reiterates Buy on Artelo ...
Benzinga Newsdesk
Monday, November 13, 2023
Artelo Biosciences Q3 EPS $(0.83) Misses $(0....
Benzinga Newsdesk
Recap: Artelo Biosciences Q3 Earnings
Benzinga Insights
Thursday, November 09, 2023
Artelo Biosciences Announces Publication Of N...
Benzinga Newsdesk
Thursday, November 02, 2023
Artelo Biosciences To Present Preclinical Dat...
Benzinga Newsdesk
Wednesday, November 01, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Monday, October 30, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Friday, October 13, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Thursday, September 07, 2023
Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Why WestRock Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Artelo Biosciences Has Completed A Pre-IND (I...
Benzinga Newsdesk
Wednesday, September 06, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Thursday, August 24, 2023
Cannabis Stock Gainers And Losers From August 24, 2023
Benzinga Insights
Tuesday, August 15, 2023
Marijuana Stock Movers For August 15, 2023
Benzinga Insights
Thursday, August 10, 2023
Artelo Q2 Net Loss Declines 33% YoY, Here Is What You Need To Know
Vuk Zdinjak
Artelo Biosciences Q2 EPS $(0.56) Up From $(0...
Benzinga Newsdesk
Monday, July 24, 2023
Cannabis Stock Movers For July 24, 2023
Benzinga Insights
Thursday, July 13, 2023
Five Studies Point To Effectiveness Of Artelo Biosciences' CBD Drug Candidate For Cancer Pain – FDA IND Application The Next Step
Johnny Rice
Tuesday, June 27, 2023
Artelo Unvails New Data On ART26.12 Demonstrating Positive Effects In Multiple Models Of Neuropathic Pain
Vuk Zdinjak
Artelo Biosciences Announces New Data On ART26.12 Demonstrating Effects In Multiple Models Of Neuropathic Pain At The 33rd Annual International Cannabinoid Research Society Symposium
Happy Mohamed
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch